Abbott FreeStyle InsuLinx - Page 57

53
References:
1
"FDA Public Health Notication: Use of Fingerstick Devices on More than One Person Poses Risk for Transmitting
Bloodborne Pathogens: Initial Communication" (2010) http://www.fda.gov/MedicalDevices/Safety/
AlertsandNotices/ucm224025.htm
2
"CDC Clinical Reminder: Use of Fingerstick Devices on More than One Person Poses Risk for Transmitting
Bloodborne Pathogens" (2010) http://www.cdc.gov/injectionsafety/Fingerstick-DevicesBGM.html
3
American Diabetes Association. Standards of Medical Care in Diabetes—2011. Diabetes Care 2011; 34 (Suppl.1)
S11-S61.
4
Diabetes Care. January 2010, vol. 33, no. Supplement 1, S11-S61.
5
Hirsch, I. (2005). Glycemic Variability: It’s Not Just About A1C Anymore! Diabetes Technology and Therapeutics,
7 (5), 780-783.
6
Mayo Clinic Proceedings February 2007, vol. 82, no. 2, 229-236.
7
Pearson J, Bergenstal R. Fine-Tuning Control: Pattern Management Versus Supplementation: View 1: Pattern
Management: an Essential Component of Eective Insulin Management. Diabetes Spectr. April 1, 2001;14(2)
75-78.